According to a nurse practitioner who works in myeloma research, nurses and APPs are responsible for much of the clinical work with patients involved in trials.
Kiah Purcell, MSN, AGPCNP-BC
Advertisement
Articles by Kiah Purcell, MSN, AGPCNP-BC
In myeloma treatment, acute CRS is a common but treatable AE associated with CAR T-cell therapy and bispecific antibodies, according to a nurse practitioner.
Advertisement
Latest Updated Articles
Monitoring Acute CRS Following T-cell Redirection Therapy for MyelomaPublished: March 19th 2025 | Updated:
Advertisement
Advertisement
Trending on Oncology Nursing News
1
Improving Access to Supportive Care on an Organizational Level, With Korie Bigbee
2
The “Owners” and “Managers” in the Peer-to-Peer Process: What an APP Should Know
3
Managing Acute and Late Adverse Effects of Breast Cancer Radiation
4
An NP’s Perspective: Supporting Derm Toxicities in Breast Cancer as a Team
5
